Author:
Trippett T.,Lin J. T.,Elisseyeff Y.,Wachter M.,Schlemmer S.,Schweitzer B.,Bertino J. R.
Publisher
Springer Berlin Heidelberg
Reference34 articles.
1. Sobrero A, Bertino JR (1986) Clinical aspects of drug resistance. Cancer Sury 5: 93–107
2. Henderson ES, Lister TA (eds) (1990) Leukemia, 5th edn. Saunders, Philadelphia
3. Schweitzer BI, Dicker AP, Bertino JR (1990) Dihydrofolate reductase as a therapeutic target. FASEB J 4: 2441–2452
4. Dedhar S, Hartley D, Goldie JH (1985) Increased dihydrofolate reductase activity in methotrexate-resistant human promyelocytic leukemia (HL-60) cells. Biochem J 225: 609–617
5. Mini E, Srimatkandada S, Medina WD, Moroson BA, Carman MD, Bertino JR (1985) Molecular and karyological analysis of methotrexate-resistant and sensitive human leukemic CCRF-CEM cells. Cancer Res 45: 317–328